Navigation Links
China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
Date:2/13/2009

TAIAN CITY, Shandong, China, Feb. 13 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that one of its R&D projects, "High-Purity Human Albumin," will be listed in the National Torch Plan of China.

The National Torch Plan was organized and executed in 1988, by China's Ministry of Science and Technology, to encourage innovation and promote the development of China's high-tech industry. Projects and enterprises listed in the plan have access to a series of support programs provided by the central and local government, including, favorable tax treatment, innovation protection, technical support, and a friendly business environment.

"We are pleased with the acceptance of our project into the National Torch Plan," said Mr. Chao Ming Zhao, CEO of China Biologic. "We view the acceptance of our project as a strong endorsement of our strategy to focus on the research and development of more technologically advanced plasma-based products. We expect that the support from the government provided by the program will enhance our competitive position in the marketplace and help us reach our goal to offer the widest range of plasma-based products in China."

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd. ("Shandong Taibang"), China Biologic Products, Inc., a Delaware corporation (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...a, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceuti...R ), a leading pharmaceutical company,specializing...of branded,generic and proprietary pharmaceuticals...ave been included in China,s National Drug Reimbur...Ministry of Human Resources and Social,Security on...
(Date:12/2/2009)... 2 According to the National Insti...ans diagnosed with diabetes already have some stag...damage to the retina caused by leaky blood vessels...betes and is one of the most feared diabetic compl...ts who,ve had diabetes for 10 years or more will e...
(Date:12/1/2009)... 1 Reportlinker.com announces that...catalogue: ,, Industrial Enzymes - A Global Ma...164431/Industrial-Enzymes---A-Global-Market-Report...poly with few strong players and a host of small s...competition and commoditization characterize the i...
(Date:12/1/2009)... Leader Richard Gephardt Brings Together A-List fr...ties for "Best and Brightest Forum on Medical Inn...wire-USNewswire/ -- Several of New Jersey,s most p...medicine and technology gathered today at the Libe...dical innovation in New Jersey, and throughout the...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
... Accera, Inc., a biotechnology company delivering...(CNS) diseases, today launched Axona(TM) in the Un... a first-in-class medical food for the clinical di...ated with mild-to-moderate Alzheimer,s. Dispensed ...cies and imbalances associated with AD by providin...
...re-FirstCall/ - Angiotech Pharmaceuticals, Inc. (N...btained a new Senior Secured Term Loan and Revolvi...he sole arranger, administrative agent and lender ...ty. , The financing includes a delayed draw secure...ecured revolving credit facility with a borrowing ...
...h 2 Bionovo, Inc.,(Nasdaq: BNVI ) today announc...le in the journal, Menopause, reporting Menerba(TM...ective for the treatment of vasomotor symptoms,(ho...use. , The Phase 2 clinical trial was designed...of Menerba versus placebo. The trial was conducted...
Other Biology Technology:Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 2Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 3Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 4Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 2Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 3Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM) 4
(Date:12/1/2009)...ose is pleased to announce the publication of resu... the efficacy and tolerability of its novel, intra...t of chronic rhinosinusitis with nasal polyps in ...nal and European Rhinologic Societies. , Chroni...sease that can significantly reduce a patient,s qu...
(Date:12/1/2009)...ble in German . , Brown adipose tissue is dif...mitochondria, miniature power stations which among...normally generate a voltage similar to that of a b...ocesses. However, the mitochondria of brown fat ce... all the time. The energy released when the fat is...
(Date:12/1/2009)...r of the 2009 Inserm Grand Prix., Every year sin...ing tribute to outstanding,work performed in its ..., Inserm intends to,demonstrate the diversity and...al, medical and,health research, and the creativi...and,drive this research each day. The Inserm 2009...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 1MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 2MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 49903 3America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Tevas Fourth Video 49901 1America Speaks Out in Favor of Affordable Healthcare and Biogenerics in Tevas Fourth Video 49901 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 1Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 3
...ay to direct chemical modifications to specific si...nal antibodies so important in the pharmaceutical ...nd her colleagues at the U.S. Department of Energy...niversity of California at Berkeley. , Many thera...an be made in bacterial systems like Escherichia ...
...s in the small Georgian town of Reepham in Norfolk...ial, led by the University of East Anglia (UEA). ...d, the properties depend on heating oil for warmth... prove that environmentally-friendly renewable hea... being used is sustainable biodiesel manufactured ...
...) Based on a striking similarity between heart di... at Columbia University Medical Center have discov...art failure may also help treat the fatal muscular...he muscle-wasting Duchenne disease couldn,t appear...fore the age of 6, destroying their muscle cells. ...
Other Biology News:Tailor-made recombinant proteins in mammals 2Tailor-made recombinant proteins in mammals 3Tailor-made recombinant proteins in mammals 4Trailblazing rural community shows green heating oil a viable option 2While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy 2
...dary Detection System uses biotin-avidin-HRP compl...rimary Antibody. The primary antibody binds to spe... antibody is removed by washing. Next, the Seconda...d and will react with the primary antibody present...
... a wide range of hands-on techniques that are usef...reas of protein chemistry and molecular biology., ...st how valuable this book will be to your research...background of a method or group of related methods...
...ed RNA (dsRNA) has been shown to induce RNA interf...insect cells in culture. RNA interference leads to... sequence-specific, dsRNA-mediated destruction of ...e RNA interference using long dsRNA in mammalian c...
...counts, similar to an infrared beam break system, ... in two frames of reference, recording can be trig...nd allow social interaction as part of the activit...avior situations, including output based on the an...
Biology Products: